139 related articles for article (PubMed ID: 1854510)
1. Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Jacobsen MB; Kolbenstvedt AN; Kolmannskog F; Bergan A; Dolva LO
Acta Oncol; 1991; 30(4):523-7. PubMed ID: 1854510
[TBL] [Abstract][Full Text] [Related]
2. Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Acta Oncol; 1989; 28(3):439-43. PubMed ID: 2742781
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894
[TBL] [Abstract][Full Text] [Related]
5. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.
Swärd C; Johanson V; Nieveen van Dijkum E; Jansson S; Nilsson O; Wängberg B; Ahlman H; Kölby L
Br J Surg; 2009 May; 96(5):517-21. PubMed ID: 19358175
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
[TBL] [Abstract][Full Text] [Related]
8. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
Strosberg JR; Choi J; Cantor AB; Kvols LK
Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
[TBL] [Abstract][Full Text] [Related]
9. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD
Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(3):881-4. PubMed ID: 1622146
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
12. Management of disseminated midgut carcinoid tumours.
Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
14. Treatment of liver metastases of carcinoid tumors.
Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.
Wängberg B; Westberg G; Tylén U; Tisell L; Jansson S; Nilsson O; Johansson V; Scherstén T; Ahlman H
World J Surg; 1996 Sep; 20(7):892-9; discussion 899. PubMed ID: 8678968
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial embolisation in patients with metastatic carcinoid tumours.
Odurny A; Birch SJ
Clin Radiol; 1985 Nov; 36(6):597-602. PubMed ID: 2415290
[TBL] [Abstract][Full Text] [Related]
19. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
Norton JA; Kerlan RK
Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
[No Abstract] [Full Text] [Related]
20. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Clouse ME; Perry L; Stuart K; Stokes KR
Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
